Viewing Study NCT06640803



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06640803
Status: RECRUITING
Last Update Posted: None
First Post: 2024-10-04

Brief Title: Sacramento Clinical High Risk for Psychosis Stepped-Care Program
Sponsor: None
Organization: None

Study Overview

Official Title: Increasing Access to Evidence-Based CHR-P Assessment and Treatment Via Stepped-Care in Community-based Settings
Status: RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SCIP Step
Brief Summary: This is a dissemination and implementation study that is evaluating a stepped-care intervention for identifying and treating youths at clinical high-risk for psychosis within multiple community mental health centers
Detailed Description: The study aims to increase the capacity to identify and treat youths at clinical high-risk for psychosis CHRp across Sacramento CA by disseminating and implementing in community mental health clinics CMHCs universal screening and a stepped-care team-based intervention that includes training and ongoing support in a Cognitive Behavioral Therapy package called Cognitive Behavioral Case Management CBCM The study is being conducted in nine non-psychosis specialty CMHCs across 5 agencies all of which treat young people with public insurance Medi-CalMedicaid or no insurance All youths aged 12-25 will be screened when beginning care and those who screen positive and agree will be assessed by the only specialty early psychosis clinic in the county at the University of California-Davis Thus the study also aims to triage this limited resource of specialized early psychosis expertise CHRp youth will then begin a 2 year stepped-care intervention at their CMHCs and can move to the early psychosis specialty clinic if they still meet CHRp criteria after 2 years or develop psychosis The specialty early psychosis service provides ongoing support and consultation

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None